多发性硬化的临床特点和治疗分析

暂未订购

导出

摘要多发性硬化(MS)是中枢神经系统的获得性炎性脱髓鞘疾病,临床上由于其症状的多样性,易被漏诊误诊.本文结合我科收治的39例MS的临床及实验室资料,探讨其临床特点及疗效.

作者陈岚桂芗湘李玫瞿浩蔡鸿

机构地区贵州省人民医院神经内科

出处《贵州医药》 CAS 2003年第6期547-547,共1页 Guizhou Medical Journal

关键词多发性硬化临床表现磁共振成像检查地塞米松强的松治疗

参考文献5

1田作军,赵薛旭,李作汉.不同免疫疗法对多发性硬化疗效的探讨[J].脑与神经疾病杂志,2001,9(5):300-302. 被引量：8
2王拥军,王林.静脉输入免疫球蛋白G治疗神经系统免疫性疾病的临床研究（综述）[J].中国神经免疫学和神经病学杂志,1996,3(3):185-188. 被引量：2
3朴翔宇.多发性硬化45例临床分析[J].脑与神经疾病杂志,2002,10(1):59-59. 被引量：4
4Poser CM. Patty DW. Scheinberg L,etal. New diagnostic criteria of MS: guideline for reseach protocols. Ann Neurol 1983,13:227.
5Kurtzke JF. Bating neurologic impairment in Multiple sclerosis. An expanded disability status scale(EDSS). Neurology.1983,33:1444 - 1452.

1[1]Poser CM, Paty TW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guildeline for research protocols[J ]. Ann Neurol, 1983,13:227～231
2[2]Lublin FD, Reingold SC. N eurology, 1996,46:907～911
3[3]Kurtzke JF. Rating neurologic impairment in multiple sclerosi s: an expanded disability status scale(EDSS). Neurology, 1983,33:1444～1452
4[4]Ferrante P, Fusi ML, Saresella M, et al. Cytokine production and surface marker expressin o in acute and stable multiple sclerosis: altered I L-12 production and augmented signaling 1ymophocytic activation molecule(SLAM) -expressing 1ymphocytes in acute multiple sclerosis. J Immunol, 1998,160:1514～1 521
5[5]Gasperini C, Pozzilli C, Bastianello S, et al. The influense of clinical relapses and steroid therapy of the development of Gd-enhanceing le sions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patie nt. Acta Neurol Scand, 1997,95:201～207
6[6]Schmidt J, Gold R, Schonrock L, et al. T-cell apoptosis in s itu experimental allergic encephalomyelitis following methylprednisolone pluse t herapy. Brain, 2000,123:1431～1441
7[7]Gayo A, Mozo L, Suarez A, et al. J Neuroimmunol, 1998,85:122～130
8[8]Comabella M, Balashov K, Issazadeh S et al. J clin Invest, 1998,102:671～678
9[9]Skeen MJ, Miller MA, Shinnick TM, et al. Immunol, 1996,156:1196～1206
10[10]Tuomanen E. Sci Am, 1993,268:80～84

贵州医药

2003年第6期

内容加载中请稍等...